The At3g47520 antibody targets the plastidial NAD-dependent malate dehydrogenase enzyme, which facilitates the reversible oxidation of malate to oxaloacetate. This enzyme is essential for photorespiration, redox balance, and metabolite shuttling between chloroplasts and mitochondria . The antibody enables researchers to investigate the protein's expression, localization, and functional roles in Arabidopsis mutants.
The antibody was generated as part of a large-scale effort to create immunocytochemistry-grade tools for Arabidopsis proteins . Key steps include:
Crude antisera were affinity-purified using recombinant malate dehydrogenase to enhance specificity. This process increased the detection success rate from 0% (crude sera) to 55% (purified antibodies) .
The antibody has been used to study malate dehydrogenase's role in:
Citrate cycle: Catalyzing malate/oxaloacetate interconversion .
Photorespiration: Balancing redox equivalents during high light stress .
Lethality of Null Alleles: Homozygous At3g47520 CRISPR mutants are embryonic lethal, underscoring the enzyme's essential role .
Phenotypic Suppression: Partial At3g47520 mutations (e.g., som410, som430) suppress cell death in the mod1 mutant, linked to altered mitochondrial retrograde signaling .